Anaptysbio, inc (ANAB)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss) Attributable to Parent

-97,336

-61,656

-30,070

-4,259

-5,405

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

514

315

183

233

274

Stock-based compensation

12,411

9,961

4,378

1,160

604

Fair Value Adjustment of Warrants

0

0

1,366

756

1,277

Accretion/amortization of investments, net

2,633

1,233

-11

0

-

(Income) loss from investments

-

-

-

-

0

Non-cash interest expense

-676

-646

-619

-105

-110

Income taxes

0

139

0

-139

139

Loss on disposal of property and equipment

-

-

-

-1

-3

Changes in operating assets and liabilities:
Receivable from collaborative partners

0

0

-1,225

-1

-229

Australian tax incentive receivable

-174

-1,427

-2,517

4,118

0

Prepaid expenses and other assets

-2,178

5,188

1,885

1,079

-204

Accounts payable and other liabilities

14,499

7,083

2,218

1,251

1,949

Deferred revenue

-

-

-

-2,942

-9,078

Net cash used in operating activities

-69,517

-48,506

-19,438

-9,030

-9,694

CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of investments

251,815

347,537

290,905

0

0

Sales and maturities of investments

384,051

206,149

48,137

0

0

Purchases of property and equipment

805

1,063

290

50

238

Net cash provided by investing activities

131,431

-142,451

-243,058

-50

-238

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Issuance of Common Stock

0

227,476

292,537

0

0

Proceeds from issuance of common stock, upon the exercise of stock options

3,000

2,869

979

31

160

Proceeds from the issuance of preferred stock, net of issuance cost

-

-

-

-

40,688

Proceeds from issuance of common stock, upon the exercise of warrants

0

76

536

0

0

Payments on notes payable

7,500

6,875

0

0

-

Proceeds from debt

-

-

-

10,000

0

Payments for repurchase of common stock

-

-

-

1

0

Payments for offering costs, net

0

182

1,599

1,147

1,445

Payments for debt issuance costs

-

-

-

255

0

Net cash used in financing activities

-4,493

223,364

292,453

8,628

39,403

Net decrease in cash, cash equivalents, and restricted cash

57,421

32,407

29,957

-452

29,471

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest paid

424

1,043

1,089

354

326

Non-cash investing and financing activities:
Fair value of warrants issued with debt

-

-

-

936

0

Amounts accrued for property and equipment

41

159

191

104

11

Amounts accrued for offering costs

0

0

37

849

760

Reclassification of warrants to equity

0

0

4,607

0

297